Patents by Inventor Anthony Kent
Anthony Kent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12173058Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: GrantFiled: February 26, 2021Date of Patent: December 24, 2024Assignee: Mereo Biopharma 3 LimitedInventors: Uwe Junker, Michaela Kneissel, Anthony Kent Hall, Rena Joy Eudy, Matthew Manning Riggs
-
Publication number: 20240400666Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: May 20, 2024Publication date: December 5, 2024Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew Manning RIGGS
-
Publication number: 20240052719Abstract: A decoupling apparatus for use in a wellbore includes a top sub section and a bottom sub section rotationally coupled to the top sub section. The bottom and top sub sections are aligned along a decoupling apparatus axis. A torque ring is disposed between the top sub section and the bottom sub section. A method for decoupling a lower tubular section from an upper tubular section of a stuck downhole tubular string including the decoupling apparatus includes identifying the stuck downhole tubular string. A first torque is applied to an upper tubular section to rotate a top sub section from a first configuration to a second configuration. A second torque is applied to the upper tubular section to rotate the top sub section from the second configuration to a third configuration in which the top and bottom sub sections are decoupled from one another.Type: ApplicationFiled: August 15, 2023Publication date: February 15, 2024Inventor: Anthony Kent
-
Publication number: 20240035361Abstract: A structural support apparatus for positioning in a downhole tubular string includes a support structure base and a liner ring having a first contact load surface in contact with a contact load surface of the base. A fastening mechanism is positioned between the base and the liner ring, where the fastening mechanism is configured to prevent movement of the liner ring relative to the base. A method for fastening a liner ring to a support structure apparatus in a downhole tubular string includes positioning a first contact load surface of the liner ring along a contact load surface of a support structure base. A second contact load surface of the liner ring is positioned along a frangible disk. A fastening mechanism is positioned between the base and the liner ring, where the fastening mechanism is configured to prevent movement of the liner ring relative to the base.Type: ApplicationFiled: July 28, 2023Publication date: February 1, 2024Inventors: Jan Tore Tveranger, Anthony Kent
-
Publication number: 20230365669Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: April 7, 2023Publication date: November 16, 2023Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew Manning RIGGS
-
Patent number: 11401781Abstract: Stimulation sleeve (1) for well intervention in a subterranean wellbore, comprising: a housing (10) having a through channel (11) with a first end (11a) and a second end (11b), and one or more flow ports (14), and a sliding sleeve (13) disposed axially movable within the housing (10) to open or close said flow ports (14). Said sliding sleeve (13) is equipped with at least a first obturator seat (15) for receipt of a obturator (17) to partially or fully close fluid communication in the through channel (11) of the housing (10), and a time delay mechanism (20) to allow the sliding sleeve (13) to axially travel in the housing (10) at a predetermined speed to open or close said flow ports (14). The invention also discloses a method for well completion in a subterranean wellbore using a sliding sleeve (1).Type: GrantFiled: November 6, 2018Date of Patent: August 2, 2022Assignee: Superstage ASInventors: Anthony Kent, Jan Tore Tveranger
-
Patent number: 11359453Abstract: Packer setting device, comprising a tubular (10) with a plug housing (14), said plug housing having an internal, through running boring (12) with an internal wall (12a), a breakable plug (16) seated in a load ring (22) axially movable within the boring (12) between a first position in where the plug (16) is with a distance to a breaking pin (18) and a second position in where the plug (16) is forced against the breaking pin (18), said load ring (22) is resting on a shear ring (20) with an annular shear lip (20a) to prevent axial movement in the first position until the shear lip (20a) is subjected to a force higher than a predetermined force, wherein the annular shear lip (20a) of the shear ring (20) extend radially inward in the boring (12), and the breaking pin (18) is resting on the shear ring (20), and said breaking pin (18) is accommodated in a pocket (28) on an outside of the load ring (22).Type: GrantFiled: December 4, 2019Date of Patent: June 14, 2022Assignee: SBS Technology ASInventor: Anthony Kent
-
Patent number: 11359457Abstract: Downhole well completion system for control of flow to or from multiple compartments (1a,1b,1c,1d) in a targeted subterranean reservoir (30), comprising a plurality of interval control valves (2) connected in series forming a downhole string (24), said interval control valves (2) are manipulated from surface via hydraulic control lines (4a, 4b, 4c) to open or close flowports (20) of each interval control valve (2), wherein each interval control valve (2) comprises a command module (5) connected to at least two of said hydraulic control lines (4a, 4b), a first hydraulic control line is a command line (4a) to deliver applied pressure to the command module (5), which translates hydraulic pressure signals into axial movement of an inner ratchet rod (6) that determines the position of an integral pilot valve (7), a second hydraulic control line is a common-open or common-close line (4b), to provide hydraulic power to either open or close the flowports (20) of each interval control valve (2), and the inner ratchetType: GrantFiled: March 8, 2019Date of Patent: June 14, 2022Assignee: Bosse Nova ASInventors: Anthony Kent, Jan Tore Overanger
-
Publication number: 20210253687Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: February 26, 2021Publication date: August 19, 2021Inventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew Manning RIGGS
-
Publication number: 20210253684Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: December 30, 2020Publication date: August 19, 2021Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew MANNING RIGGS
-
Publication number: 20210095543Abstract: Downhole well completion system for control of flow to or from multiple compartments (1a,1b,1c,1d) in a targeted subterranean reservoir (30), comprising a plurality of interval control valves (2) connected in series forming a downhole string (24), said interval control valves (2) are manipulated from surface via hydraulic control lines (4a, 4b, 4c) to open or close flowports (20) of each interval control valve (2), wherein each interval control valve (2) comprises a command module (5) connected to at least two of said hydraulic control lines (4a, 4b), a first hydraulic control line is a command line (4a) to deliver applied pressure to the command module (5), which translates hydraulic pressure signals into axial movement of an inner ratchet rod (6) that determines the position of an integral pilot valve (7), a second hydraulic control line is a common-open or common-close line (4b), to provide hydraulic power to either open or close the flowports (20) of each interval control valve (2), and the inner ratchetType: ApplicationFiled: March 8, 2019Publication date: April 1, 2021Inventors: Anthony Kent, Jan Tore Overanger
-
Patent number: 10961305Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: GrantFiled: December 21, 2017Date of Patent: March 30, 2021Assignee: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe Junker, Michaela Kneissel, Anthony Kent Hall, Rena Joy Eudy, Matthew Manning Riggs
-
Patent number: 10900323Abstract: Stimulation sleeve (1) for well intervention in a subterranean wellbore, comprising: a housing (10) having a through channel (11) with a first end (11a) and a second end (11b), and one or more flow ports (14), and a sliding sleeve (13) disposed axially movable within the housing (10) to open or close said flow ports (14). Said sliding sleeve (13) is equipped with at least a first obturator seat (15) for receipt of a obturator (17) to partially or fully close fluid communication in the through channel (11) of the housing (10), and a time delay mechanism (20) to allow the sliding sleeve (13) to axially travel in the housing (10) at a predetermined speed to open or close said flow ports (14). The invention also discloses a method for well completion in a subterranean wellbore using a sliding sleeve (1).Type: GrantFiled: February 8, 2018Date of Patent: January 26, 2021Inventor: Anthony Kent
-
Publication number: 20210017837Abstract: Stimulation sleeve (1) for well intervention in a subterranean wellbore, comprising: a housing (10) having a through channel (11) with a first end (11a) and a second end (11b), and one or more flow ports (14), and a sliding sleeve (13) disposed axially movable within the housing (10) to open or close said flow ports (14). Said sliding sleeve (13) is equipped with at least a first obturator seat (15) for receipt of a obturator (17) to partially or fully close fluid communication in the through channel (11) of the housing (10), and a time delay mechanism (20) to allow the sliding sleeve (13) to axially travel in the housing (10) at a predetermined speed to open or close said flow ports (14). The invention also discloses a method for well completion in a subterranean wellbore using a sliding sleeve (1).Type: ApplicationFiled: November 6, 2018Publication date: January 21, 2021Inventors: Anthony Kent, Jan Tore Tveranger
-
Publication number: 20200179509Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: December 21, 2017Publication date: June 11, 2020Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew MANNING RIGGS
-
Publication number: 20200182007Abstract: Packer setting device, comprising a tubular (10) with a plug housing (14), said plug housing having an internal, through running boring (12) with an internal wall (12a), a breakable plug (16) seated in a load ring (22) axially movable within the boring (12) between a first position in where the plug (16) is with a distance to a breaking pin (18) and a second position in where the plug (16) is forced against the breaking pin (18), said load ring (22) is resting on a shear ring (20) with an annular shear lip (20a) to prevent axial movement in the first position until the shear lip (20a) is subjected to a force higher than a predetermined force, wherein the annular shear lip (20a) of the shear ring (20) extend radially inward in the boring (12), and the breaking pin (18) is resting on the shear ring (20), and said breaking pin (18) is accommodated in a pocket (28) on an outside of the load ring (22).Type: ApplicationFiled: December 4, 2019Publication date: June 11, 2020Inventor: ANTHONY KENT
-
Publication number: 20200123242Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: January 2, 2020Publication date: April 23, 2020Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew MANNING RIGGS
-
Publication number: 20190330322Abstract: Disclosed are methods for treating a patient suffering from osteogenesis imperfecta comprising administering to the patient a therapeutically effective amount of an anti-sclerostin antibody. Methods for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient by administering to the patient a therapeutically effective amount of an anti-sclerostin antibody are also disclosed. Further disclosed are compositions for increasing bone formation and reducing bone resorption in an osteogenesis imperfecta patient. The compositions comprise a therapeutically effective amount of an anti-sclerostin antibody. The invention also provides an anti-sclerostin antibody for use in the treatment of osteogenesis imperfecta.Type: ApplicationFiled: December 21, 2017Publication date: October 31, 2019Applicant: MEREO BIOPHARMA 3 LIMITEDInventors: Uwe JUNKER, Michaela KNEISSEL, Anthony Kent HALL, Rena Joy EUDY, Matthew Manning RIGGS
-
Publication number: 20190136666Abstract: Stimulation sleeve (1) for well intervention in a subterranean wellbore, comprising: a housing (10) having a through channel (11) with a first end (11a) and a second end (11b), and one or more flow ports (14), and a sliding sleeve (13) disposed axially movable within the housing (10) to open or close said flow ports (14). Said sliding sleeve (13) is equipped with at least a first obturator seat (15) for receipt of a obturator (17) to partially or fully close fluid communication in the through channel (11) of the housing (10), and a time delay mechanism (20) to allow the sliding sleeve (13) to axially travel in the housing (10) at a predetermined speed to open or close said flow ports (14). The invention also discloses a method for well completion in a subterranean wellbore using a sliding sleeve (1).Type: ApplicationFiled: February 8, 2018Publication date: May 9, 2019Applicant: ENTECH SOLUTION ASInventor: Anthony Kent
-
Patent number: 6980410Abstract: An active lightning protection system and method is disclosed. According to one embodiment of the invention, the active lightning protection system includes a charge sensor that senses the build-up of charge associated with an imminent lightning strike in the proximity of a structure and a charge source to supply an opposite charge into the proximity to offset the build-up, thereby reducing the possibility of a strike to the structure.Type: GrantFiled: October 8, 2002Date of Patent: December 27, 2005Inventor: Charles Anthony Kent